Department of Internal Medicine, Chuncheon Sacred Heart Hospital, Hallym University College of Medicine, Sakju-ro 77, Chuncheon-si 24253, Gangwon-do, Korea.
Department of Nursing Science, Hallym Polytechnic University, Janghak-gil 48, Dong-myeon, Chuncheon-si 242120, Gangwon-do, Korea.
Medicina (Kaunas). 2022 Mar 2;58(3):369. doi: 10.3390/medicina58030369.
Sepsis is an emergent infectious disease and a leading cause of death despite immediate intervention. While Delta neutrophil index (DNI) and myeloperoxidase (MPO) are known as a prodiagnostic marker of sepsis, the preclinical evidence of the best marker of sepsis is unclear. For this, using a well-designed cecal ligation and puncture (CLP)-induced sepsis mouse model, we comparatively measured the level and cost-effectiveness of sepsis biomarkers such as DNI, myeloperoxidase (MPO), procalcitonin (PCT), and tumor necrosis factor-alpha (TNF-α). First, we found that the optimal time point for early detection is at 6 h, 24 h post-CLP. Strikingly, the peak level and fold change of DNI was revealed at 24 h, further showing the best fold change as compared with other biomarker levels. Given the fold change at 6, 24 h, PCT was next to DNI. Third, a cost-effectiveness survey showed that DNI was the best, with PCT next. Further, DNI level was moderate positively associated with PCT (ρ = 0.697, = 0.012) and TNF-α (ρ = 0.599, = 0.040). Collectively, these data indicate that DNI in CLP-induced sepsis mice is as effective as the existent inflammatory biomarkers such as MPO, PCT and TNF-α to predict the prognosis of sepsis. This might have clinically important implications that DNI is cost effective, thus quickly and rationally applying to diverse types of imminent sepsis regardless of species. This might be the first report on the validity of DNI in preclinical CLP-induced murine sepsis.
脓毒症是一种紧急感染性疾病,尽管立即进行干预,但其仍是主要死亡原因。虽然 Delta 中性粒细胞指数 (DNI) 和髓过氧化物酶 (MPO) 是脓毒症的已知早期诊断标志物,但脓毒症最佳标志物的临床前证据尚不清楚。为此,我们使用精心设计的盲肠结扎穿刺 (CLP) 诱导的脓毒症小鼠模型,比较了 DNI、髓过氧化物酶 (MPO)、降钙素原 (PCT) 和肿瘤坏死因子-α (TNF-α) 等脓毒症生物标志物的水平和成本效益。首先,我们发现早期检测的最佳时间点是 CLP 后 6 小时和 24 小时。引人注目的是,DNI 的峰值水平和变化倍数在 24 小时时显示出,与其他生物标志物水平相比,进一步显示出最佳的变化倍数。考虑到 6 小时和 24 小时的变化倍数,PCT 仅次于 DNI。第三,成本效益调查显示,DNI 是最佳的,其次是 PCT。此外,DNI 水平与 PCT(ρ=0.697, = 0.012)和 TNF-α(ρ=0.599, = 0.040)呈中度正相关。总之,这些数据表明,CLP 诱导的脓毒症小鼠中的 DNI 与现有的炎症生物标志物(如 MPO、PCT 和 TNF-α)一样有效,可预测脓毒症的预后。这可能具有重要的临床意义,即 DNI 具有成本效益,因此可以快速、合理地应用于各种潜在的脓毒症,而不受物种的限制。这可能是 DNI 在临床前 CLP 诱导的小鼠脓毒症中有效性的首次报道。